Vitamin D therapy in chronic kidney disease and end stage renal disease

Michal L. Melamed; Ravi I. Thadhani

doi:10.2215/CJN.04040411

Vitamin D therapy in chronic kidney disease and end stage renal disease

Michal L. Melamed, Ravi I. Thadhani

Medicine

Research output: Contribution to journal › Article › peer-review

97 Scopus citations

Abstract

Vitamin D has garnered much research and debate about supplementation in recent years, not only as it pertains to patients with kidney disease but also to those in the general population. This review discusses observational and available clinical trial evidence about the effects of both calcitriol and vitamin D analogs (active) and ergo-calciferol and cholecalciferol (nutritional) vitamin D in patients with CKD and ESRD.

Original language	English (US)
Pages (from-to)	358-365
Number of pages	8
Journal	Clinical Journal of the American Society of Nephrology
Volume	7
Issue number	2
DOIs	https://doi.org/10.2215/CJN.04040411
State	Published - Feb 1 2012

ASJC Scopus subject areas

Epidemiology
Critical Care and Intensive Care Medicine
Nephrology
Transplantation

Access to Document

10.2215/CJN.04040411

Cite this

@article{66e2480f3aff491ca46c0ecadac518c0,

title = "Vitamin D therapy in chronic kidney disease and end stage renal disease",

abstract = "Vitamin D has garnered much research and debate about supplementation in recent years, not only as it pertains to patients with kidney disease but also to those in the general population. This review discusses observational and available clinical trial evidence about the effects of both calcitriol and vitamin D analogs (active) and ergo-calciferol and cholecalciferol (nutritional) vitamin D in patients with CKD and ESRD.",

author = "Melamed, {Michal L.} and Thadhani, {Ravi I.}",

year = "2012",

month = feb,

day = "1",

doi = "10.2215/CJN.04040411",

language = "English (US)",

volume = "7",

pages = "358--365",

journal = "Clinical Journal of the American Society of Nephrology",

issn = "1555-9041",

publisher = "American Society of Nephrology",

number = "2",

}

TY - JOUR

T1 - Vitamin D therapy in chronic kidney disease and end stage renal disease

AU - Melamed, Michal L.

AU - Thadhani, Ravi I.

PY - 2012/2/1

Y1 - 2012/2/1

N2 - Vitamin D has garnered much research and debate about supplementation in recent years, not only as it pertains to patients with kidney disease but also to those in the general population. This review discusses observational and available clinical trial evidence about the effects of both calcitriol and vitamin D analogs (active) and ergo-calciferol and cholecalciferol (nutritional) vitamin D in patients with CKD and ESRD.

AB - Vitamin D has garnered much research and debate about supplementation in recent years, not only as it pertains to patients with kidney disease but also to those in the general population. This review discusses observational and available clinical trial evidence about the effects of both calcitriol and vitamin D analogs (active) and ergo-calciferol and cholecalciferol (nutritional) vitamin D in patients with CKD and ESRD.

UR - http://www.scopus.com/inward/record.url?scp=84857175985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857175985&partnerID=8YFLogxK

U2 - 10.2215/CJN.04040411

DO - 10.2215/CJN.04040411

M3 - Article

C2 - 22193236

AN - SCOPUS:84857175985

SN - 1555-9041

VL - 7

SP - 358

EP - 365

JO - Clinical Journal of the American Society of Nephrology

JF - Clinical Journal of the American Society of Nephrology

IS - 2

ER -

Vitamin D therapy in chronic kidney disease and end stage renal disease

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this